Analyst Reiterates Buy on Omnicell, Citing Once-in-a-Decade Product Cycle Momentum and Margin Strength; Price Target Maintained at $70

Bank of America Securities analyst Allen Lutz reiterated a Buy rating on Omnicell yesterday and set a price target of $70.00.

Allen Lutz has given his Buy rating due to a combination of factors including Omnicell’s solid margin execution and the early momentum in what he views as a once-in-a-decade product cycle. He highlights that strong interest in the Titan XT platform, evidenced by a sharp increase in demo equipment needs, underpins his confidence in a meaningful bookings acceleration in late 2026 and 2027.

He also points to better-than-expected tariff mitigation and cost controls, which are driving higher EBITDA estimates and supporting a more favorable margin outlook. Despite the stock’s recent move, he notes that shares still trade well below the company’s long-term valuation multiples on his 2028 EBITDA framework, leaving room for multiple expansion as bookings improve, and therefore he reiterates a Buy rating with an unchanged $70 price target.

In another report released today, KeyBanc also assigned a Buy rating to the stock with a $70.00 price target.